Dan Ives, the head of technology research at Wedbush, has reiterated his optimism for IBM (IBM). This time, by raising the price target on the tech titan to $350 from $320 earlier. The revised price target implies an upside potential of about 15% from current levels. However, if Ives and his team of analysts are to be believed, the target price should have been higher.

“Based on our recent research, IBM’s portfolio across AI, hybrid cloud, automation, and cybersecurity continues to demonstrate strong momentum. Clients are seeking trusted, scalable, and compliant solutions that can be deployed in complex environments. As more enterprises begin large-scale AI…